Sepsis: Protocolized care for critically ill patients with AKI
Nature Reviews Nephrology 11, 10 (2015).
doi:10.1038/nrneph.2014.204
Authors: Bantayehu Sileshi & Andrew Shaw
Findings from the ARISE and TRISS trials indicate that protocolized therapy might be no better than contemporary management for patients in intensive care, and that in the absence of coronary disease a haemoglobin level of 70 g/l should be the new trigger for transfusion in patients with sepsis.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Bantayehu SileshiAndrew Shaw Tags: News and Views Source Type: research
More News: Intensive Care | Urology & Nephrology